CRO – Contract Research Organisation

CRO- Institut für klinische Forschung - Dr. Oestreich + Partner GmbH

In its capacity as a CRO (Contract Research Organisation) the company Dr. Oestreich + Partner GmbH, provides budget, time and goal-oriented consultancy and support for clinical studies. The spectrum of services provided ranges from the initial budget planning through to successful conduct and reporting of clinical trials in the prevention, treatment, care and economics of diverse medical indications. Our broad network of local clinical monitors and partners with ICH-GCP experience enables flexible implementation of our CRO – Contract Research Organisation - services in a very broad range of clinical studies at home and abroad.

The CRO (Contrat Research Organisation), which was founded in 1991, has extensive experience in clinical research. Our highly qualified and extremely competent team supports our customers with a comprehensive range of services. We carry out national and international clinical research projects for the prevention, treatment, care and economics of all medical conditions and issues.

CRO - Contract Research Organisation - Individual Solutions for Greater Flexibility

As a CRO (Contract Research Organisation), our areas of responsibility include the preparation of all the necessary documents - from regulatory submissions to the authorities and protocol development for clinical trials in prophylaxis, therapy, supply and economics of all medical indications and issues; the drafting of investigator contracts through to the writing of publications. As a CRO (Contract Research Organisation) we are very happy to additionally carry out comprehensive literature reviews and the translation of texts and documentation. We design, draft and create case report forms (CRFs) according to the different trial endpoints. Our Electronic Data Capture (EDC) systems OPVERDI and PMSBOX additionally allow the individual creation of multilingual fast online eCRFs. At the same time, those with authorised access to these data bases may access all relevant data in real time, which enables project participants to organise their work in an extremely flexible manner.

We monitor clinical trials from Phase I to IV, and recruit and instruct trial sites and laboratories. In addition, we conduct both the on-site and online monitoring of clinical trials, and carry out audits and implement other quality assurance measures. At the same time, the CRO’s (Contract Research Organisation’s) project management personnel closely track the project budget and accounting, while all the time ensuring careful and rigorous pursuit of our clients’ objectives.

A detailed overview of our Contract Rsearch Organisation (CRO) is found here:

EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
GCP Guidelines
GCP Compliance
Clinical Research Organisation
Contract Research Organisation
Pharmacoeconomics, Health
Pharmacoeconomic studies
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection